Sign in
4

Changes in Ownership

Mosaic ImmunoEngineering Inc. Filed Acc 0001144204-06-023929

Options or other derivatives

  • CEO acquired 1,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

POHL DAVID · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2006-06-05 Grant or award : show line 1 in the form Stock Option (right to buy) +1,500,000 1,500,000 D
Loading xslF345X02/v044820_ex.xml…